Chapter I · Title band

Biocan | M Plus vacuna contra la dermatofitosis por Microsporum canis para perros (1 dosis) Dextrovitam B12 subgingivalmente 118101

Name: Biocan | M Plus vacuna contra la dermatofitosis por Microsporum canis para perros (1 dosis) Dextrovitam B12 subgingivalmente 118101
Brand: growinghearts.net
SKU: 42936727794
Price: 29.90 USD
Availability: InStock
Rating: 4.882000000000001 (27 reviews)

SKU 42936727794 · ★ 4.9

Chapter II · Gallery

Biocan | M Plus vacuna contra la dermatofitosis por Microsporum canis para perros (1 dosis) Dextrovitam B12 subgingivalmente 118101

Chapter III · Acquire

EUR29.90 EUR75.90

Pay in 4 interest-free payments of $7.47 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Oct 21 - Oct 26

Court notes

Description

Biocan M Plus vacuna contra la dermatofitosis por Microsporum canis para perros (1 dosis) Dextrovitam B12 subgingivalmente 118101 subgingivalmente Energía metabolizable: 3 850 kcal kg Biocan M Plus es una vacuna inactivada de Bioveta para la prevención y el tratamiento de la micosis de la piel (dermatofitosis) en perros causada por el dermatofito Microsporum canis Uso terapéutico: se requiere una tercera dosis a los 10 a 21 días de la segunda

Exchange/Return Notes

We offer a 30-day return/exchange service after receiving.
Final sale items are not eligible for returns or exchanges.
To process your return/exchange, please contact us at [email protected]
Please click here for more details>>> Return & Exchange Policy

Frequently Asked Questions for Biocan | M Plus vacuna contra la dermatofitosis por Microsporum canis para perros (1 dosis) Dextrovitam B12 subgingivalmente 118101

How can I get useful help from the seller about a product or order?

Include the relevant listing wording if you are asking about an ambiguous claim. Check whether a separate contact is designated for a particular order issue.

How can I decide whether this product meets my needs?

Think about whether a simpler option would meet the same need. Consider any additional requirements needed to get the intended benefit.

What should I record if a purchase-related problem happens only sometimes?

Record changes to the arrangement that might provide useful context. Avoid submitting repeated identical reports without additional relevant information.